Antioxidant-Conjugated 1,2,4-Triazolo[4,3-<i>a</i>]pyrazin-3-one Derivatives: Highly Potent and Selective Human A<sub>2A</sub> Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic PainMatteo Falsini, Vittoria Colotta, Diego Dal Ben et al.|Journal of Medicinal Chemistry|2019Cited by 21
Discovery of first-in-class multi-target adenosine A2A receptor antagonists-carbonic anhydrase IX and XII inhibitors. 8-Amino-6-aryl-2-phenyl-1,2,4-triazolo [4,3-a]pyrazin-3-one derivatives as new potential antitumor agentsCostanza Ceni, Vittoria Colotta, Flavia Varano et al.|European Journal of Medicinal Chemistry|2020Cited by 11
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonistsMatteo Falsini, Vittoria Colotta, Flavia Varano et al.|Bioorganic & Medicinal Chemistry Letters|2020Cited by 7
Design, synthesis and muscarinic activity of deoxamuscarine-related derivativesAlessandro Piergentili, Wilma Quaglia, Roberto Gagliardi et al.|Unicam Scientific Publications (University of Camerino)|2002Cited by 1
8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemiaSara Calenda, Vittoria Colotta, Flavia Varano et al.|Bioorganic Chemistry|2025Cited by 0